StockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)

Stock analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a research report issued on Tuesday. The brokerage set a “buy” rating on the stock.

Mannatech Stock Down 1.8 %

Shares of MTEX opened at $8.35 on Tuesday. The stock has a market cap of $15.69 million, a price-to-earnings ratio of -6.95 and a beta of 1.20. The company has a quick ratio of 0.51, a current ratio of 1.07 and a debt-to-equity ratio of 0.09. Mannatech has a 12 month low of $7.50 and a 12 month high of $15.93. The company has a 50-day moving average price of $8.68 and a two-hundred day moving average price of $8.84.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Mannatech stock. Tower Research Capital LLC TRC boosted its holdings in shares of Mannatech, Incorporated (NASDAQ:MTEX) by 167.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,575 shares of the company’s stock after purchasing an additional 987 shares during the period. Tower Research Capital LLC TRC owned about 0.08% of Mannatech worth $27,000 as of its most recent SEC filing. 12.98% of the stock is owned by institutional investors.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels.